MarketSmith India Names Five Stocks for Investors to Consider on March 18

Indian Stock Market Update - 18 March

The domestic benchmark indices, Nifty 50 and Sensex, continued their upward trend on Tuesday, March 17, supported by gains in the metals sector and a recovery in automobile stocks. Despite concerns regarding elevated crude oil prices, the Nifty 50 advanced by 0.74% to reach 23,581.15, while the BSE Sensex increased by 0.75% to 76,070.84.

Market Outlook

The stock markets have risen by 1.9% and 2% over the past two sessions this week after confirming a technical correction last week. However, the near-term outlook suggests a range-bound market with a cautious bias, where global cues, crude oil movements, and currency trends will remain the key drivers. A decisive breakout above resistance or clarity on global macro triggers will be essential for a sustained directional move.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Stocks to Buy Today

Based on technical analysis and market trends, the following stocks are recommended for purchase:

• Federal Bank Ltd: Buy above ₹266 with a stop loss of ₹250 and a target price of ₹289 (multiday). Federal Bank is a leading Indian private-sector bank offering comprehensive retail, corporate, and NRI banking services.
• Aurobindo Pharma Ltd: Buy above ₹1,298 with a stop loss of ₹1,245 and a target price of ₹1,410 (multiday). Aurobindo Pharma is a leading Indian multinational pharmaceutical company that manufactures and sells generic drugs, Active Pharmaceutical Ingredients (APIs), and formulations across therapeutic areas.
• Vardhman Textiles: Buy above ₹1,235 with a stop loss of ₹1,180 and a target price of ₹1,350 (multiday).
• Tata Power: Buy above ₹143.50 with a stop loss of ₹136 and a target price of ₹155 (multiday).
• Data Patterns (India): Buy above ₹1,025 with a stop loss of ₹955 and a target price of ₹1,150 (multiday).

Key Metrics

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

• Federal Bank Ltd:

• P/E: 16.88
• 52-week high: ₹301.75
• Volume: 12.84M

• Aurobindo Pharma Ltd:

• P/E: 23.45
• 52-week high: ₹1,415.50
• Volume: 4.53M

Risk Factors

• Intense competition leading to margin pressure
• Asset quality concerns in specific portfolios
• Regulatory changes

Disclaimer

This report is for informational purposes only and should not be considered as investment advice. It is essential to conduct thorough research and consult with a financial advisor before making any investment decisions.